首页> 外国专利> COMBINED APPLICATION OF ANTI-TUMOR DERIVATIVE OF INDOLOPYRROLOCARBAZOLE AND ANOTHER ANTITUMOR AGENT

COMBINED APPLICATION OF ANTI-TUMOR DERIVATIVE OF INDOLOPYRROLOCARBAZOLE AND ANOTHER ANTITUMOR AGENT

机译:吲哚并吡咯并吲哚类抗肿瘤药与另一种抗肿瘤剂的联合应用

摘要

The present invention relates to a combined preparation for simultaneous, separate or sequential administration in the treatment of cancer, containing two separate preparations: a preparation containing at least one compound of general formula I in combination with a pharmaceutically acceptable carrier or diluent, where each of the substituents R and R is independently of each other is a hydrogen atom, lower alkyl or others. and G is pentosyl or others, X and X, each independently of one another, is a hydrogen atom, atoms m halogen or other, or its pharmaceutically acceptable sa and the drug in combination with a pharmaceutically acceptable carrier or diluent, such as antitumor alkylating agents, antitumor antimetabolites, antitumor antibiotics or antitumor agents of plant origin (a preparation containing at least one compound of general formula I or its pharmaceutically acceptable salt, can be combined with two or more other anticancer agents), and a method of treating cancer, which involves the introduction of these drugs in combination.International This was published with the international search report.
机译:本发明涉及在癌症治疗中同时,分开或依次给药的组合制剂,其包含两种单独的制剂:包含至少一种通式I化合物与药学上可接受的载体或稀释剂的制剂,其中每种取代基R 1和R 2彼此独立地是氢原子,低级烷基或其他。 G是戊基或其他,X和X彼此独立地是氢原子,卤素或其他原子或它们的药学上可接受的盐;以及与药物可接受的载体或稀释剂(例如抗肿瘤烷基化剂,抗肿瘤抗代谢物,抗肿瘤抗生素或植物来源的抗肿瘤剂)组合的药物(含有至少一种通式I化合物或其药学上可接受的盐的制剂可以是(与两种或多种其他抗癌药联合使用),以及一种治疗癌症的方法,其中包括将这些药物联合引入。国际(International)随国际检索报告一起发表。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号